SUFLAVE
Peakpolyethylene glycol 3350, sodium sulfate, potassium chloride, magnesium sulfate, and sodium chloride for oral solution
NDAORALFOR SOLUTION
Approved
Jun 2023
Lifecycle
Peak
Competitive Pressure
0/100
Data completeness
3/8 — Basic
Drug data last refreshed 16h ago · AI intelligence enriched 19h ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
SUFLAVE is an oral solution containing polyethylene glycol 3350, sodium sulfate, potassium chloride, magnesium sulfate, and sodium chloride — a bowel preparation agent approved in June 2023. It is used for cleansing the colon prior to colonoscopy or other diagnostic procedures. The osmotic and electrolyte composition works to evacuate intestinal contents without significant systemic absorption.
$0.462MPart D
Peak18.0 years to LOEEarly-stage branded bowel prep with modest Part D adoption; commercial team likely focused on healthcare provider education and procedure-center partnerships to drive volume growth.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
SUFLAVE offers career opportunities in commercial roles focused on procedure-center penetration, provider education, and competitive positioning against established bowel prep brands. The early-peak lifecycle and minimal linked job activity suggest a lean, efficient team structure typical of specialty GI products with defined market segments.
Brand ManagerField Sales Representative
Worked on SUFLAVE at R-Pharm US? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.